search
Back to results

MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients With Multiple Sclerosis (MSNEUROPLAST)

Primary Purpose

Multiple Sclerosis, Cognitive Decline

Status
Recruiting
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Cognitive Training
Sponsored by
Aristotle University Of Thessaloniki
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Multiple Sclerosis focused on measuring EEG, Network Efficiency, Adaptive, Plasticity, Maladaptive Reorganization, Cognitive Training

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Male/female patients aged 18 to 55 years at screening
  • Diagnosis of MS according to the 2017 Revised McDonald criteria
  • Disability status at screening with an EDSS score of 0 to 5.5
  • Relapsing MS and progressive MS as defined by Lublin
  • Disability status at screening with an EDSS score of 0 to 5.5
  • Neurologically stable within 1 month prior to screening
  • Years from MS diagnosis: ≤ 10 for relapsing patients, ≤ 15 for progressive patients
  • Patients receiving the same Disease Modifying Treatment (DMT) for at least 6 months

Exclusion Criteria:

  • Patients suspected of not being able or willing to cooperate or comply with study protocol requirements
  • Patients meeting criteria for other demyelinating diseases of the CNS
  • Patients with active chronic disease (or stable but treated with immune therapy) of the immune system other than MS
  • Patients with any other significant CNS disease or serious psychiatric disorder which can interfere with the patient's ability to cooperate or comply with the study procedure
  • Patients unable or unwilling to undergo MRI scans and EEG

Sites / Locations

  • Laboratory of Medical Physics and Digital Innovation, AUTHRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

No Intervention

No Intervention

Arm Label

PwMS-CogTr

PwMS-Con

Heal-Con

Arm Description

Adult individuals with Multiple Sclerosis will follow a cognitive training intervention. Neurological assessment History of Multiple Sclerosis Expanded Disability Status Scale (EDSS) 2 types of high-density electroencephalographic recordings at rest with eyes closed (10 minutes) event potentials via a multisensory oddball paradigm (45 minutes) Neuropsychological assessment MMSE CDT GVLT BVMT SDMT Verbal Fluency: Phonemic [ Chi-Sigma-Alpha] and Semantic [Animals-Fruits-Objects] Digit Span (For-Back-Seq)_WAIS-4GR SNST GAT DASS21 MSIS-29 CRIq MFIS EQ-5D-5L BDI-II Somatometric assessment Timed 25-Foot Walk (T25-FW) 3m backwards walk test Hole Peg Test (9-HPT) Handgrip Strength Test Single Leg Stance (SLS) Four Square Step Test (FSST) BrainHQ training

Adult individuals with Multiple Sclerosis serving as passive controls. Neurological assessment History of Multiple Sclerosis Expanded Disability Status Scale (EDSS) 2 types of high-density electroencephalographic recordings at rest with eyes closed (10 minutes) event potentials via a multisensory oddball paradigm (45 minutes) Neuropsychological assessment Mini Mental Status Examination (MMSE) Clock Drawing Test (CDT) Greek Verbal Learning Test (GVLT) Brief Visuospatial Memory Test (BVMT) Symbol Digit Modalities Test (SDMT) Verbal Fluency: Phonemic [ Chi-Sigma-Alpha] and Semantic [Animals-Fruits-Objects] Digit Span (For-Back-Seq)_WAIS-4GR Stroop Neuropsychological Test (SNST) The Greek Accentuation Test (GAT) DASS-21 MSIS-29 CRIq MFIS EQ-5D-5L BDI-II Somatometric assessment T25-FW 3m backwards walk test 9-HPT Handgrip Strength Test SLS FSST

Healthy adults serving as passive controls. 2 types of high-density electroencephalographic recordings at rest with eyes closed (10 minutes) event potentials via a multisensory oddball paradigm (45 minutes) Neuropsychological assessment Mini Mental Status Examination (MMSE) Greek Verbal Learning Test (GVLT) Brief Visuospatial Memory Test (BVMT) Symbol Digit Modalities Test (SDMT) Somatometric assessment Timed 25-Foot Walk (T25-FW) 3m backwards walk test Hole Peg Test (9-HPT) Handgrip Strength Test Single Leg Stance (SLS) Four Square Step Test (FSST)

Outcomes

Primary Outcome Measures

Change in current density strength of the cortical activity as measured via EEG
Changes in cortical activity strength caused via the training. Change is defined as statistical significance in the t-test comparison of the current density strength as reconstructed via Low Resolution Electromagnetic Tomography (LORETA) algorithm on the basis of high-density EEG recordings, before compared to after the training.
Change in cortical connectivity as measured via EEG
Changes in cortical connectivity caused via the training. Change is defined as statistical significance in the t-test comparison of Phase Transfer Entropy estimated from the cortical activity, as reconstructed via LORETA algorithm on the basis of high density EEG recordings, before compared to after the training.
Changes in the graph theory indexes as measured via EEG
Changes in the global and local graph theoretical indices of the brain networks caused via the training. Change is defined as statistical significance in the t-test comparison of the graph theory indices before compared to after the training.

Secondary Outcome Measures

Change in audiovisual integration functionality
Change of accuracy in the behavioral measurement testing audiovisual integration. Change is defined as statistical significance in the t-test comparison before compared to after the training. A lower score denotes a decline.
Change in Mini Mental Status Examination (MMSE)
The Mini-Mental State Exam (MMSE) is a test of cognitive function. It includes tests of orientation, attention, memory, language, and visual-spatial skills. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 100 (max). A lower score denotes a decline.
Change in Clock Drawing Test (CDT)
The Clock-Drawing Test (CDT) is a simple and effective cognitive test used to assess executive function and visual-spatial function. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 15 (max). A lower score denotes a decline.
Change in Brief Visuospatial Memory Test (BVMT)
The Brief Visuospatial Memory Test (BVMT) measures visuospatial memory. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 36 (max). A lower score denotes a decline.
Change in Symbol Digit Modalities Test (SDMT)
The Symbol Digit Modalities Test (SDMT) is a screening instrument to assess cognitive function and especially processing speed. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 110 (max). Scoring involves summing the number of correct substitutions within the 90-second interval. A lower score denotes a decline.
Change in Verbal Fluency: Phonemic [ Chi-Sigma-Alpha]
Verbal Fluency: Phonemic [ Chi-Sigma-Alpha] is a test of verbal fluency to evaluate the ability to retrieve specific information within restricted search parameters. It can be used as an efficient screening instrument for general verbal functioning. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 to as many as many different words as possible generated beginning with each of the following three Greek letters: X (Chi), S (Sigma), and A (Alpha) within 60 seconds. A lower score denotes a decline.
Change in Verbal Fluency: Semantic [Animals-Fruits-Objects]
Verbal Fluency: Semantic [Animals-Fruits-Objects] is a test of verbal fluency to evaluate the ability to retrieve specific information within restricted search parameters. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 to as many as many unique words as possible generated within a semantic category (Animals, Fruits, Objects) in 60 seconds. A lower score denotes a decline.
Change in Digit Span (For-Back-Seq) _WAIS-4GR
Digit Span (For-Back-Seq) _WAIS-4GR is a tool to measure one's verbal short-term and working memory. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 48 (max). A lower score denotes a decline.
Change in Stroop Neuropsychological Test (SNST)
Stroop Neuropsychological Test (SNST) provides a brief screening for brain damage, dysfunction of selective attention, and cognitive flexibility. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to the sum of correct answers within 2 minutes. A lower score denotes a decline.
Change in Greek Accentuation Test (GAT)
The Greek Accentuation Test (GAT) is a test of premorbid intellectual functioning. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 50 (max). A lower score denotes a decline.
Change in Depression Anxiety Stress Scale (DASS-21)
Depression Anxiety Stress Scale (DASS-21) is a self-report scale designed to measure the negative emotional states of depression, anxiety, and stress. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 63 (max). A lower score denotes an amelioration or absence of symptoms.
Change in Multiple Sclerosis Impact Scale (MSIS-29)
Multiple sclerosis Impact Scale (MSIS-29) measures coordination, fatigue, flexibility, muscle performance, muscle tone/spasticity, balance/falls, reach and grasp, self-care, health and wellness, leisure, quality of life, role function, social function, and work. A 29-item, self-report questionnaire designed to measure the physical and psychological impact of MS. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 29 (min) to 116 (max). A lower score denotes an amelioration or absence of symptoms.
Change in the Cognitive Reserve Questionnaire (CRIq)
The Cognitive Reserve Questionnaire (CRIq) is an instrument for measuring cognitive reserve. Change is defined as statistical significance in the comparison between before and after the training. The questionnaire is divided into 3 sections: CRI-Education, CRI-WorkingActivity, CRI-LeisureTime. The CRIq score falls into 1 of 5 ordered levels: low (less than 70); medium-low (70-84); medium (85-114); medium-high (115-130); and high (more than 130). A lower score means a lower cognitive reserve.
Change in Modified Fatigue Impact Scale (MFIS)
The Modified Fatigue Impact Scale (MFIS) is a structured, self-report questionnaire that concerns how fatigue impacts their lives. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 84 (max). A lower score denotes an amelioration or absence of symptoms.
Change in EQ-5D-5L
The EQ-5D-5L is a self-assessed, health-related, quality-of-life questionnaire. The scale measures the quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Change is defined as statistical significance in the comparison between before and after the training. A lower score denotes an amelioration or absence of symptoms.
Change in EQ-5D-5L -EQ-VAS
Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0% (min) to 100% (max). The lower the score, the worse the perception of health.
Change in Beck Depression Inventory-Fast Screen (BDI-FS)
Beck Depression Inventory-Fast Screen (BDI-FS) is a 21-question self-report inventory for measuring the severity of depression. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 21 (max). A lower score denotes an amelioration or absence of symptoms.
Change in Timed 25-Foot Walk (T25-FW)
The Timed 25-Foot Walk (T25-FW) assesses walking speed and general walking ability on a ~8m (7.62m) corridor. The T25FW score is calculated by averaging the two tests performed (in seconds). Time limit per trial: 3 minutes (180 seconds). Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Change in 3 m backwards walk test
The 3 m backwards walk test assesses backward walking which is more sensitive to detecting changes in mobility and balance than walking forward. The score records the time (in seconds) per trial. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Change in Hole Peg Test (9-HPT)
The Hole Peg Test (9-HPT) is a brief, standardized, quantitative test that assesses upper extremity functionality, looking at how well the patient can use both their primary and non-primary hand to perform a specific task. Time limit per trial: 5 minutes (300 seconds). Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Change in Four Square Step Test (FSST)
The Four Square Step Test (FSST) assesses dynamic stability and the subject's ability to step over low objects forward, sideways, and backward. The aim is to step as fast as possible into each square with both feet in the following sequence: Square 2, 3, 4, 1, 4, 3, 2, 1 (clockwise to counterclockwise). The best time (in seconds) of two FSST is the score. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Change in Single Leg Stance Test (SLS)
The Single Leg Stance Test (SLS): assesses static postural and balance control and is a valuable clinical tool for monitoring neurological and musculoskeletal status as well as for managing fall risk. It is tested on both legs. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Change in the Handgrip Strength Test
The Handgrip Strength Test assesses endurance to the maximum strength of the upper limbs. Grip strength is typically measured in kilograms by squeezing a type of muscle strength testing equipment, known as a dynamometer in each hand. The average healthy grip strength for men is a squeeze of about 33kg while women typically measure around 20kg. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of squeeze denotes improvement.

Full Information

First Posted
March 3, 2021
Last Updated
May 3, 2023
Sponsor
Aristotle University Of Thessaloniki
Collaborators
King Fahad Medical City
search

1. Study Identification

Unique Protocol Identification Number
NCT04806568
Brief Title
MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients With Multiple Sclerosis
Acronym
MSNEUROPLAST
Official Title
Cognitive Decline Prognosis in Multiple Sclerosis: Effectiveness of a Computerized Cognitive Training Treatment on Cortical Reorganization
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 1, 2020 (Actual)
Primary Completion Date
October 31, 2023 (Anticipated)
Study Completion Date
June 7, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aristotle University Of Thessaloniki
Collaborators
King Fahad Medical City

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This clinical study aims to identify MS related beneficial plasticity and by contrast maladaptive reorganization in combination with elements of daily functional status as a response to a cognitive training program
Detailed Description
Cognitive decline is a debilitating and widespread comorbidity of Multiple Sclerosis (MS) affecting up to 65 percent of patients with MS (PwMS). Cognitive changes can be the only behavioral index of MS activity. But how accurately and timely can these be captured? The existing clinical tools are subjective and do not have the dynamic of prognosis. It remains uncertain how much change in cognitive status is required to translate into a meaningful clinical outcome and how long it may subsequently take to become apparent. Moving towards a holistic approach, MS-NEUROPLAST aims to further expand previously-published prognostic marker candidates and previous work of the applicant and the members of the research team and employ a group of methodologies for interventions and applications which will quantify via real-world assessment the MS-related cognitive changes in order to characterize not only decline but given the right dosage of stimulation improvement as well. MS-NEUROPLAST has three main objectives: (i) Utilize state of-the-art neuroimaging and network science measures to more thoroughly understand neural indices of cognitive impairment in PwMS. (ii) Evaluate the efficacy for treating MS-associated cognitive deficits using a computerized cognitive training treatment by determining the differences, between subjects treated with cognitive training and controls, on network science measures indexing network efficiency or collapse and on the performance of a battery of neuropsychological tests that are frequently impaired in MS. (iii) Investigate the dissociation of the cortical mechanisms related to training-induced plasticity and maladaptive reorganization (namely separate good from bad), by taking into account the homeostatic capacity of the human organism as a whole and thus examining whether the correlation of the neurophysiological and cognitive indices with longitudinal digital biomarkers of daily functional status can capture the underlying pathology. MS-NEUROPLAST stages for PwMS Provide signed informed consent to participate in the study after being informed by the principal investigator. Neurological evaluation and decision on whether the inclusion criteria are met. The participants will visit the Medical Physics & Digital Innovation Lab at AUTH, where: A. They will undergo a neuropsychological and somatometric assessment B. Then, they will undergo an electroencephalogram (EEG) measurement which includes the following: Placement of the EEG cap holding the electrodes on the head to record the electrical activity of the brain. The cap will be soaked with potassium chloride solution to maintain the electrodes' resistance at desired levels Wear over ear headphones Recording EEG activity at rest for 10 minutes with eyes closed View and listen to a series of simple images and sounds in video format and parallel recording of EEG evoked potentials using a complex eccentric (oddball) protocol combining multisensory audiovisual mismatches with unisensory acoustic and visual deviancies. Concurrently to the EEG measurements the subjects will respond behaviourally via button presses to an audiovisual congruency task on which they have to evaluate whether the images presented correspond to the tones they hear based on the rule: "the higher the pitch of the tone the higher the position of the circle". The recording will be performed 4 times, will include 32 sequences from each category audiovisual congruent, audiovisual incongruent, auditory deviant and visual deviant) resulting in 128 measurements from each condition for each participant. The measurement will take about 45 minutes. C. Familiarization with using a personal computer or a tablet, and demonstration of both the BrainHQ environment for cognitive training and the wearable and ambient devices. Use of a set of smart sensors to collect biomarkers (steps, calories, sleep duration, heart rate, oxygen saturation) of daily activities for a period of up to 1 month (at least 2 weeks) before the onset of cognitive training. This will be followed by cognitive training through BrainHQ exercises. The training should be performed with a frequency of at least 3 times a week, for about 60 minutes (30 minutes of pure practice), lasting up to 12 weeks. Adherence will be recorded by the BrainHQ application and any deviations from the schedule will be followed by communication via the telephone or in person aimed at mobilizing and re engaging participants. During cognitive training, the recording of biomarkers of daily activities will continue. At the end of the training, stages 3A and 3B will be repeated. MS-NEUROPLAST stages for Healthy Controls Provide signed informed consent to participate in the study after being informed by the principal investigator The participants will visit the Medical Physics & Digital Innovation Lab at AUTH, where: A. They will undergo a neuropsychological and somatometric assessment B. Then, they will undergo an electroencephalogram (EEG) measurement which includes the following: Placement of the EEG cap holding the electrodes on the head to record the electrical activity of the brain. The cap will be soaked with potassium chloride solution to maintain the electrodes' resistance at desired levels Wear over ear headphones Recording EEG activity at rest for 10 minutes with eyes closed View and listen to a series of simple images and sounds in video format and parallel recording of EEG evoked potentials using a complex eccentric (oddball) protocol combining multisensory audiovisual mismatches with unisensory acoustic and visual deviancies. Concurrently to the EEG measurements the subjects will respond behaviourally via button presses to an audiovisual congruency task on which they have to evaluate whether the images presented correspond to the tones they hear based on the rule: "the higher the pitch of the tone the higher the position of the circle". The recording will be performed 4 times, will include 32 sequences from each category audiovisual congruent, audiovisual incongruent, auditory deviant and visual deviant) resulting in 128 measurements from each condition for each participant. The measurement will take about 45 minutes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis, Cognitive Decline
Keywords
EEG, Network Efficiency, Adaptive, Plasticity, Maladaptive Reorganization, Cognitive Training

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants are assigned to either the intervention or control group.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PwMS-CogTr
Arm Type
Experimental
Arm Description
Adult individuals with Multiple Sclerosis will follow a cognitive training intervention. Neurological assessment History of Multiple Sclerosis Expanded Disability Status Scale (EDSS) 2 types of high-density electroencephalographic recordings at rest with eyes closed (10 minutes) event potentials via a multisensory oddball paradigm (45 minutes) Neuropsychological assessment MMSE CDT GVLT BVMT SDMT Verbal Fluency: Phonemic [ Chi-Sigma-Alpha] and Semantic [Animals-Fruits-Objects] Digit Span (For-Back-Seq)_WAIS-4GR SNST GAT DASS21 MSIS-29 CRIq MFIS EQ-5D-5L BDI-II Somatometric assessment Timed 25-Foot Walk (T25-FW) 3m backwards walk test Hole Peg Test (9-HPT) Handgrip Strength Test Single Leg Stance (SLS) Four Square Step Test (FSST) BrainHQ training
Arm Title
PwMS-Con
Arm Type
No Intervention
Arm Description
Adult individuals with Multiple Sclerosis serving as passive controls. Neurological assessment History of Multiple Sclerosis Expanded Disability Status Scale (EDSS) 2 types of high-density electroencephalographic recordings at rest with eyes closed (10 minutes) event potentials via a multisensory oddball paradigm (45 minutes) Neuropsychological assessment Mini Mental Status Examination (MMSE) Clock Drawing Test (CDT) Greek Verbal Learning Test (GVLT) Brief Visuospatial Memory Test (BVMT) Symbol Digit Modalities Test (SDMT) Verbal Fluency: Phonemic [ Chi-Sigma-Alpha] and Semantic [Animals-Fruits-Objects] Digit Span (For-Back-Seq)_WAIS-4GR Stroop Neuropsychological Test (SNST) The Greek Accentuation Test (GAT) DASS-21 MSIS-29 CRIq MFIS EQ-5D-5L BDI-II Somatometric assessment T25-FW 3m backwards walk test 9-HPT Handgrip Strength Test SLS FSST
Arm Title
Heal-Con
Arm Type
No Intervention
Arm Description
Healthy adults serving as passive controls. 2 types of high-density electroencephalographic recordings at rest with eyes closed (10 minutes) event potentials via a multisensory oddball paradigm (45 minutes) Neuropsychological assessment Mini Mental Status Examination (MMSE) Greek Verbal Learning Test (GVLT) Brief Visuospatial Memory Test (BVMT) Symbol Digit Modalities Test (SDMT) Somatometric assessment Timed 25-Foot Walk (T25-FW) 3m backwards walk test Hole Peg Test (9-HPT) Handgrip Strength Test Single Leg Stance (SLS) Four Square Step Test (FSST)
Intervention Type
Other
Intervention Name(s)
Cognitive Training
Intervention Description
The cognitive training treatment is a Greek adaptation of BrainHQ developed by Posit Science Corporation. The intervention will target speed, attention, working memory, and executive function through the visual and auditory domains via a set of 15 exercises. Each daily training session consists of four exercises chosen from an active set of six. Participants will be instructed to train for one hour per day, three days per week, over 12 weeks via a tablet. Each subject will receive at least 29 sessions of computerized cognitive training.
Primary Outcome Measure Information:
Title
Change in current density strength of the cortical activity as measured via EEG
Description
Changes in cortical activity strength caused via the training. Change is defined as statistical significance in the t-test comparison of the current density strength as reconstructed via Low Resolution Electromagnetic Tomography (LORETA) algorithm on the basis of high-density EEG recordings, before compared to after the training.
Time Frame
3 months
Title
Change in cortical connectivity as measured via EEG
Description
Changes in cortical connectivity caused via the training. Change is defined as statistical significance in the t-test comparison of Phase Transfer Entropy estimated from the cortical activity, as reconstructed via LORETA algorithm on the basis of high density EEG recordings, before compared to after the training.
Time Frame
3 months
Title
Changes in the graph theory indexes as measured via EEG
Description
Changes in the global and local graph theoretical indices of the brain networks caused via the training. Change is defined as statistical significance in the t-test comparison of the graph theory indices before compared to after the training.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Change in audiovisual integration functionality
Description
Change of accuracy in the behavioral measurement testing audiovisual integration. Change is defined as statistical significance in the t-test comparison before compared to after the training. A lower score denotes a decline.
Time Frame
3 months
Title
Change in Mini Mental Status Examination (MMSE)
Description
The Mini-Mental State Exam (MMSE) is a test of cognitive function. It includes tests of orientation, attention, memory, language, and visual-spatial skills. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 100 (max). A lower score denotes a decline.
Time Frame
3 months
Title
Change in Clock Drawing Test (CDT)
Description
The Clock-Drawing Test (CDT) is a simple and effective cognitive test used to assess executive function and visual-spatial function. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 15 (max). A lower score denotes a decline.
Time Frame
3 months
Title
Change in Brief Visuospatial Memory Test (BVMT)
Description
The Brief Visuospatial Memory Test (BVMT) measures visuospatial memory. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 36 (max). A lower score denotes a decline.
Time Frame
3 months
Title
Change in Symbol Digit Modalities Test (SDMT)
Description
The Symbol Digit Modalities Test (SDMT) is a screening instrument to assess cognitive function and especially processing speed. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 110 (max). Scoring involves summing the number of correct substitutions within the 90-second interval. A lower score denotes a decline.
Time Frame
3 months
Title
Change in Verbal Fluency: Phonemic [ Chi-Sigma-Alpha]
Description
Verbal Fluency: Phonemic [ Chi-Sigma-Alpha] is a test of verbal fluency to evaluate the ability to retrieve specific information within restricted search parameters. It can be used as an efficient screening instrument for general verbal functioning. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 to as many as many different words as possible generated beginning with each of the following three Greek letters: X (Chi), S (Sigma), and A (Alpha) within 60 seconds. A lower score denotes a decline.
Time Frame
3 months
Title
Change in Verbal Fluency: Semantic [Animals-Fruits-Objects]
Description
Verbal Fluency: Semantic [Animals-Fruits-Objects] is a test of verbal fluency to evaluate the ability to retrieve specific information within restricted search parameters. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 to as many as many unique words as possible generated within a semantic category (Animals, Fruits, Objects) in 60 seconds. A lower score denotes a decline.
Time Frame
3 months
Title
Change in Digit Span (For-Back-Seq) _WAIS-4GR
Description
Digit Span (For-Back-Seq) _WAIS-4GR is a tool to measure one's verbal short-term and working memory. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 48 (max). A lower score denotes a decline.
Time Frame
3 months
Title
Change in Stroop Neuropsychological Test (SNST)
Description
Stroop Neuropsychological Test (SNST) provides a brief screening for brain damage, dysfunction of selective attention, and cognitive flexibility. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to the sum of correct answers within 2 minutes. A lower score denotes a decline.
Time Frame
3 months
Title
Change in Greek Accentuation Test (GAT)
Description
The Greek Accentuation Test (GAT) is a test of premorbid intellectual functioning. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 50 (max). A lower score denotes a decline.
Time Frame
3 months
Title
Change in Depression Anxiety Stress Scale (DASS-21)
Description
Depression Anxiety Stress Scale (DASS-21) is a self-report scale designed to measure the negative emotional states of depression, anxiety, and stress. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 63 (max). A lower score denotes an amelioration or absence of symptoms.
Time Frame
3 months
Title
Change in Multiple Sclerosis Impact Scale (MSIS-29)
Description
Multiple sclerosis Impact Scale (MSIS-29) measures coordination, fatigue, flexibility, muscle performance, muscle tone/spasticity, balance/falls, reach and grasp, self-care, health and wellness, leisure, quality of life, role function, social function, and work. A 29-item, self-report questionnaire designed to measure the physical and psychological impact of MS. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 29 (min) to 116 (max). A lower score denotes an amelioration or absence of symptoms.
Time Frame
3 months
Title
Change in the Cognitive Reserve Questionnaire (CRIq)
Description
The Cognitive Reserve Questionnaire (CRIq) is an instrument for measuring cognitive reserve. Change is defined as statistical significance in the comparison between before and after the training. The questionnaire is divided into 3 sections: CRI-Education, CRI-WorkingActivity, CRI-LeisureTime. The CRIq score falls into 1 of 5 ordered levels: low (less than 70); medium-low (70-84); medium (85-114); medium-high (115-130); and high (more than 130). A lower score means a lower cognitive reserve.
Time Frame
3 months
Title
Change in Modified Fatigue Impact Scale (MFIS)
Description
The Modified Fatigue Impact Scale (MFIS) is a structured, self-report questionnaire that concerns how fatigue impacts their lives. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 84 (max). A lower score denotes an amelioration or absence of symptoms.
Time Frame
3 months
Title
Change in EQ-5D-5L
Description
The EQ-5D-5L is a self-assessed, health-related, quality-of-life questionnaire. The scale measures the quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Change is defined as statistical significance in the comparison between before and after the training. A lower score denotes an amelioration or absence of symptoms.
Time Frame
3 months
Title
Change in EQ-5D-5L -EQ-VAS
Description
Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0% (min) to 100% (max). The lower the score, the worse the perception of health.
Time Frame
3 months
Title
Change in Beck Depression Inventory-Fast Screen (BDI-FS)
Description
Beck Depression Inventory-Fast Screen (BDI-FS) is a 21-question self-report inventory for measuring the severity of depression. Change is defined as statistical significance in the comparison between before and after the training. The score ranges from 0 (min) to 21 (max). A lower score denotes an amelioration or absence of symptoms.
Time Frame
3 months
Title
Change in Timed 25-Foot Walk (T25-FW)
Description
The Timed 25-Foot Walk (T25-FW) assesses walking speed and general walking ability on a ~8m (7.62m) corridor. The T25FW score is calculated by averaging the two tests performed (in seconds). Time limit per trial: 3 minutes (180 seconds). Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Time Frame
3 months
Title
Change in 3 m backwards walk test
Description
The 3 m backwards walk test assesses backward walking which is more sensitive to detecting changes in mobility and balance than walking forward. The score records the time (in seconds) per trial. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Time Frame
3 months
Title
Change in Hole Peg Test (9-HPT)
Description
The Hole Peg Test (9-HPT) is a brief, standardized, quantitative test that assesses upper extremity functionality, looking at how well the patient can use both their primary and non-primary hand to perform a specific task. Time limit per trial: 5 minutes (300 seconds). Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Time Frame
3 months
Title
Change in Four Square Step Test (FSST)
Description
The Four Square Step Test (FSST) assesses dynamic stability and the subject's ability to step over low objects forward, sideways, and backward. The aim is to step as fast as possible into each square with both feet in the following sequence: Square 2, 3, 4, 1, 4, 3, 2, 1 (clockwise to counterclockwise). The best time (in seconds) of two FSST is the score. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Time Frame
3 months
Title
Change in Single Leg Stance Test (SLS)
Description
The Single Leg Stance Test (SLS): assesses static postural and balance control and is a valuable clinical tool for monitoring neurological and musculoskeletal status as well as for managing fall risk. It is tested on both legs. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of timing denotes improvement.
Time Frame
3 months
Title
Change in the Handgrip Strength Test
Description
The Handgrip Strength Test assesses endurance to the maximum strength of the upper limbs. Grip strength is typically measured in kilograms by squeezing a type of muscle strength testing equipment, known as a dynamometer in each hand. The average healthy grip strength for men is a squeeze of about 33kg while women typically measure around 20kg. Change is defined as statistical significance in the comparison between before and after the training. An increased measure of squeeze denotes improvement.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria for people with MS: Male/female patients aged 18 to 55 years at screening Diagnosis of MS according to the 2017 Revised McDonald criteria Disability status at screening with an EDSS score of 0 to 6.5 Relapsing MS and progressive MS as defined by Lublin Disability status at screening with an EDSS score of 0 to 5.5 Neurologically stable within 1 month prior to screening Years from MS diagnosis: ≤ 10 for relapsing patients 15 for progressive patients Patients receiving the same Disease Modifying Treatment (DMT) for at least 6 months Exclusion Criteria for people with MS: Patients suspected of not being able or willing to cooperate or comply with study protocol requirements Patients meeting criteria for other demyelinating diseases of the CNS Patients with active chronic disease (or stable but treated with immune therapy) of the immune system other than MS Patients with any other significant CNS disease or serious psychiatric disorder which can interfere with the patient's ability to cooperate or comply with the study procedure Patients unable or unwilling to undergo MRI scans and EEG Inclusion Criteria for Healthy Controls: • Normal hearing and normal or corrected-to-normal vision Exclusion Criteria for Healthy Controls: Any diagnosed neurological, mental, developmental, or psychiatric disorder Unrecovered neurological disorders (i.e., stroke, traumatic brain injury) Unstable medication within the last 3 months Intake of central nervous drugs (e.g., antidepressants) Severe physical disorder, and Concurrent participation in another relevant study Patients unable or unwilling to undergo EEG measurements
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Charis Styliadis, PhD
Phone
6942618582
Ext
+30
Email
styliadis@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Panagiotis D Bamidis, PhD
Email
bamidis@auth.gr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charis Styliadis, PhD
Organizational Affiliation
Aristotle University Of Thessaloniki
Official's Role
Principal Investigator
Facility Information:
Facility Name
Laboratory of Medical Physics and Digital Innovation, AUTH
City
Thessaloníki
State/Province
Central Macedonia
ZIP/Postal Code
54124
Country
Greece
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Charis Styliadis, PhD
Phone
6942618582
Email
styliadis@hotmail.com
First Name & Middle Initial & Last Name & Degree
Panagiotis D Bamidis, PhD
First Name & Middle Initial & Last Name & Degree
Nikolaos Grigoriadis, PhD
First Name & Middle Initial & Last Name & Degree
Vahe Poghosyan, PhD
First Name & Middle Initial & Last Name & Degree
Ioannis Nikolaidis, PhD
First Name & Middle Initial & Last Name & Degree
Antonis Billis, PhD
First Name & Middle Initial & Last Name & Degree
Vasiliki Zilidou, PhD
First Name & Middle Initial & Last Name & Degree
Panagiotis Kartsidis, MSc
First Name & Middle Initial & Last Name & Degree
Alexandra Anagnostopoulou, MSc

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25945260
Citation
Styliadis C, Kartsidis P, Paraskevopoulos E, Ioannides AA, Bamidis PD. Neuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states. Neural Plast. 2015;2015:172192. doi: 10.1155/2015/172192. Epub 2015 Apr 7.
Results Reference
background
PubMed Identifier
26973445
Citation
Klados MA, Styliadis C, Frantzidis CA, Paraskevopoulos E, Bamidis PD. Beta-Band Functional Connectivity is Reorganized in Mild Cognitive Impairment after Combined Computerized Physical and Cognitive Training. Front Neurosci. 2016 Feb 29;10:55. doi: 10.3389/fnins.2016.00055. eCollection 2016.
Results Reference
background
Links:
URL
http://cstyliadis.webpages.auth.gr/MS-NEUROPLAST-EN.html
Description
MS-NEUROPLAST webpage
URL
https://www.facebook.com/profile.php?id=100066598856507
Description
MS-NEUROPLAST Facebook page

Learn more about this trial

MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients With Multiple Sclerosis

We'll reach out to this number within 24 hrs